Researchers



Results 61-80 of 144
Issue DateTitleAuthor(s)TypeМp-cat.
2024Effect of tirzepatide on blood pressure levels in overweight/obese individuals without diabetesPatoulias, Dimitrios; Popovic, Djordje S  ; Koufakis, Theocharis; Stavropoulos, Konstantinos; Doumas, MichaelReviews
21aM21a
2024Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?Popovic, Djordje S  ; Patoulias, Dimitrios; Koufakis, Theocharis; Stavropoulos, Konstantinos; Karakasis, Paschalis; Ruza, Ieva; Papanas, Nikolaos; Rizzo, Manfredi; Doumas, MichaelArticle
22M22
2024Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough SeasPapantoniou, Eleni; Arvanitakis, Konstantinos; Markakis, Konstantinos; Papadakos, Stavros P; Tsachouridou, Olga; Popovic, Djordje S  ; Germanidis, Georgios; Koufakis, Theocharis; Kotsa, KalliopiArticle
21M21
2024The Effect of Sodium-Glucose Cotransporter Inhibitors on Renal Function as Adjunctive to Insulin in Adults with Type 1 Diabetes: An Updated Multilevel Meta-analysis of Randomized Controlled TrialsKarakasis, Paschalis; Popovic, Djordje S  ; Patoulias, Dimitrios; Koufakis, Theocharis; Papanas, Nikolaos; Fragakis, Nikolaos; Rizzo, ManfrediArticle
22M22
2023Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individualsKarras, Spyridon NN; Koufakis, Theocharis; Dimakopoulos, Georgios; Popovic, Djordje S  ; Kotsa, KalliopiReviews
21M21
2023Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus?Popovic, Djordje S  ; Stoian, Anca Pantea; Papanas, NikolaosReviews
22M22
2023Should tirzepatide be considered for early management in type 2 diabetes? Pros and consKoufakis, Theocharis; Popovic, Djordje S  ; Papanas, NikolaosContribution to periodical
22M22
2023GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations and Practical Recommendations for Safe and Effective UseArvanitakis, Konstantinos; Koufakis, Theocharis; Popović, Đorđe S  ; Maltese, Giuseppe; Mustafa, Omar; Doumas, Michael; Giouleme, Olga; Kotsa, Kalliopi; Germanidis, GeorgiosArticle
21a+M21a+
2023Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow?Gouveri, Evanthia; Popovic, Djordje S  ; Papanas, NikolaosArticle
22M22
2023Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert PanelPopović, Đorđe S  ; Papanas, Nikolaos; Koufakis, Theocharis; Kotsa, Kalliopi; Mahmeed, Wael Al; Al-Rasadi, Khalid; (broj koautora 28)Article
22M22
2023Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trialsPatoulias, Dimitrios; Popovic, Djordje S  ; Pantea-Stoian, Anca; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, ManfrediArticle
22M22
2023Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysisKarakasis, Paschalis; Patoulias, Dimitrios; Pamporis, Konstantinos; Popovic, Djordje S  ; Stachteas, Panagiotis; Bougioukas, Konstantinos I; Fragakis, Nikolaos; Rizzo, ManfrediArticle
21aM21a
2023The new evidence on cardiorenal benefits of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: one step closer to their use in this setting?Popovic, Djordje S  ; Koufakis, Theocharis; Patoulias, Dimitrios; Papanas, NikolaosArticle
21M21
2023The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled TrialsBica, Ioana-Cristina; Stoica, Roxana Adriana; Salmen, Teodor; Janez, Andrej; Volcansek, Spela; Popovic, Đorđe S  ; Muzurovic, Emir; Rizzo, Manfredi; Stoian, Anca PanteaArticle
21M21
2023Are SGLT-2 inhibitors "the elephant in the room" of non-diabetic glomerulonephritis? Considerations about the background immunosuppressive treatmentPatoulias, Dimitrios; Popovic, Djordje S  Reviews
22M22
2023The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better!Popovic, Djordje S  ; Koufakis, Theocharis; Papanas, NikolaosArticle
21M21
2023Circulating follistatin as a novel biomarker of type 2 diabetes mellitus riskPapachristou, Stella; Popovic, Djordje S  ; Papanas, NikolaosReviews
23M23
2023Contrast-Associated Acute Kidney Injury: More Frequent Among Patients With Diabetic Foot UlcersPopovic, Djordje S  ; Papanas, NikolaosContribution to periodical
22M22
2023Zinc Levels and Diabetic Foot Ulcers: A Mini ReviewKarakousis, Nikolaos D; Pyrgioti, Elisavet E; Georgakopoulos, Petros N; Apergi, Kyriaki; Popovic, Djordje S  ; Papanas, NikolaosArticle
22M22
2023A Mediterranean Eating Pattern Combining Energy and Time-Restricted Eating Improves Vaspin and Omentin Concentrations Compared to Intermittent Fasting in Overweight IndividualsKarras, Spyridon N; Koufakis, Theocharis; Popovic, Djordje S  ; Adamidou, Lilian; Karalazou, Paraskevi; Thisiadou, Katerina; Zebekakis, Pantelis; Makedou, Kali; Kotsa, KalliopiArticle
21M21